These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7179130)

  • 21. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunopathogenic aspects of chronic viral hepatitis].
    Moreno Otero R; García Buey L; García Monzón C
    Rev Clin Esp; 1996 Mar; 196(3):179-84. PubMed ID: 8650389
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of hepatitis B surface antigen (HBsAg) and antibody (HBsAb) in civilian blood donors in Delhi area.
    Narain S; Gupta ML; Maheshwari HB; Mittal MM
    Indian J Public Health; 1981; 24(3):163-9. PubMed ID: 7251107
    [No Abstract]   [Full Text] [Related]  

  • 24. Some pathogenic features of viral hepatitis.
    Babeş VT
    Virologie; 1978; 29(3):171-5. PubMed ID: 358559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B surface antigenemia and HLA antigens.
    Giani G; Chiaramonte M; Pasini CV; Fagiolo U; Naccarato R
    N Engl J Med; 1979 May; 300(18):1056. PubMed ID: 431606
    [No Abstract]   [Full Text] [Related]  

  • 27. [Non-A, non-B hepatitis or hepatitis C?].
    Lumio J
    Duodecim; 1980; 96(11):772-6. PubMed ID: 6783384
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibody-dependent, cell-mediated cytotoxicity in the course of acute hepatitis].
    Zähringer T; Schumacher K; Maerker-Alzer G; Hackstein-Anders C; Gross R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1857-9. PubMed ID: 801093
    [No Abstract]   [Full Text] [Related]  

  • 29. [Viral markers of acute hepatitis].
    Jirón MI; Armas Merino R; Ramón Soto J; Wolff C
    Rev Med Chil; 1982 Dec; 110(12):1234-6. PubMed ID: 7184111
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Family study on the possible relationship between chronic HBsAg carriers and HLA system haplotypes].
    Montoro JA; Soler MA; Carrasco D; Pérez Castellanos MT; Carbonell F; Ruiz I; Berenguer J; Marty ML
    Sangre (Barc); 1983; 28(2):158-63. PubMed ID: 6879397
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 36. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis B markers (HBsAg and HBsAb) in women screened at time of delivery.
    Naggan L; Bar-Shany S; Shmuelewitz O; Finzi M; Prywes R
    Isr J Med Sci; 1980 May; 16(5):347-50. PubMed ID: 7399863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients.
    Verdon R; Pol S; Landais P; Mattlinger B; Carnot F; Brechot C; Busson M; Kreis H
    J Hepatol; 1994 Sep; 21(3):388-93. PubMed ID: 7836709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal immune complexes in viral hepatitis.
    Sehgal S; Datta BN; Chugh KS; Aikat BK; Datta DV
    Clin Exp Immunol; 1980 Jun; 40(3):453-8. PubMed ID: 6998616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg.
    Koziol DE; Alter HJ; Kirchner JP; Holland PV
    J Immunol; 1976 Dec; 117(6):2260-2. PubMed ID: 993599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.